PCV25 COST EFFECTIVENESS OF ATORVASTATIN (LIPITOR) AS SINGLE THERAPY AND DUAL THERAPY WITH EZETIMIBE (ZETIA)
May 1, 2005, 00:00
10.1016/S1098-3015(10)62666-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)62666-6/fulltext
Title :
PCV25 COST EFFECTIVENESS OF ATORVASTATIN (LIPITOR) AS SINGLE THERAPY AND DUAL THERAPY WITH EZETIMIBE (ZETIA)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62666-6&doi=10.1016/S1098-3015(10)62666-6
First page :
Section Title :
Open access? :
No
Section Order :
103